MM-236: Outcomes among High-Risk Newly Diagnosed Multiple Myeloma Treated with High-Dose Chemotherapy and Autologous Stem Cell Transplantation (HDCT/ASCT) in the Era of Novel Agents: A Retrospective Single-Center Analysis
2020 ◽
Vol 20
◽
pp. S303-S304
2002 ◽
Vol 17
(4)
◽
pp. 537
◽
2020 ◽
Vol 68
(3)
◽
pp. 139-144
◽
2018 ◽
Vol 24
(3)
◽
pp. S48
◽
2020 ◽
Vol 41
(3)
◽
pp. 288-293
◽
2015 ◽
Vol 51
(2)
◽
pp. 227-231
◽
2013 ◽
Vol 28
(2)
◽
pp. 220
◽
2004 ◽
Vol 131
(4)
◽
pp. 214-218
◽